EL
25
-2
BWA
55
-5
MSI
47
3
AAP
26
-7
ACN
22
6
MKC
38
2
SPG
30
3
NWL
39
-2
ITW
48
9
AES
46
2
QRVO
59
6
PLD
58
2
CCI
39
9
SWK
46
-3
ADP
39
3
PNW
69
2
MO
45
-2
AAL
16
-13
BEN
55
-2
D
58
5
EL
25
-2
BWA
55
-5
MSI
47
3
AAP
26
-7
ACN
22
6
MKC
38
2
SPG
30
3
NWL
39
-2
ITW
48
9
AES
46
2
QRVO
59
6
PLD
58
2
CCI
39
9
SWK
46
-3
ADP
39
3
PNW
69
2
MO
45
-2
AAL
16
-13
BEN
55
-2
D
58
5
Financhill
Back

Clene, Inc. 10K Form

Sell
45

CLNN
Clene, Inc.

Last Price:
$5.21
Seasonality Move:
-8.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-03-29 10K CLNN/Clene, Inc. Annual
2020-11-03 10Q CLNN/Clene, Inc. Quarterly
2020-09-04 10K CLNN/Clene, Inc. Annual
2020-08-03 10Q CLNN/Clene, Inc. Quarterly
2020-05-14 10Q CLNN/Clene, Inc. Quarterly
2020-03-24 10K CLNN/Clene, Inc. Annual

Receive CLNN News And Ratings

See the #1 stock for the next 7 days that we like better than CLNN

CLNN Financial Statistics

Sales & Book Value

Annual Sales: $200K
Cash Flow: $-4.9M
Price / Cash Flow: 0
Annual Sales: $-1.62
Price / Book: 13.16

Profitability

EPS (TTM): -2.59760
Net Income (TTM): $-26.2M
Gross Margin: $-1.3M
Return on Equity: -4726.49%
Return on Assets: -113.58%

Clene, Inc. Earnings Forecast

Key Clene, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for CLNN is -669.00%.
  • The Selling, General & Administrative Expenses for CLNN have been equal to 4,614.50% of Gross Profit Margin.
  • The Research & Development expenses have been 6,330.00% of Revenue.
  • The Net Earning history of CLNN is -13,086.50% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Clene, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLNN
CUSIP: 185634
Website: clene.com

Debt

Debt-to-Equity Ratio: -1.23
Current Ratio: 0.83
Quick Ratio: 0.48

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLNN Technical Analysis vs Fundamental Analysis

Sell
45
Clene, Inc. (CLNN) is a Sell

Is Clene, Inc. a Buy or a Sell?

  • Clene, Inc. stock is rated a Sell
    The current Clene, Inc. [CLNN] share price is $5.12. The Score for CLNN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.